Drug Database
Back to search

Switzerland· 67621001

Vividrin 0.5 mg/ml, Augentropfen

A azelastine product, registered in Switzerland by Bausch & Lomb Swiss AG and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.

Cat B (Swissmedic)ATC S01GX07

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedVividrin 0.5 mg/ml, AugentropfenATCS01GX07REGISTER NO.67621001PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about VividrinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azelastine is registered in 10 of 19 countries.

Countries holding a registration under ATC S01GX07 (azelastine), each read from that country’s own register.

  • This record: Switzerland
  • 6 of them publish a price we can compare per daily dose
Search azelastine products by name

Azelastine · ATC S01GX07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Bausch & Lomb Swiss AG
Country
Switzerland (CH)
ATC code
S01GX07
ATC class
Azelastine
Defined daily dose
0.1 mg, AT
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for azelastine.

Graded by severity as the source publishes them — 1 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azelastine against other medicinesHow interaction checks work

Azelastine · interactions on record

1 record

  • 1 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same class

    Other records under S01GX07

    Azelastine, as other registers publish it.

    All azelastine products

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/c3744ec6-9852-4567-8ee4-00551a000e1d
GET /v1/drugs/c3744ec6-9852-4567-8ee4-00551a000e1d?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
    API referenceMCP serverPlans

    See everything about azelastine.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console